BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34572686)

  • 21. Healthcare trajectory of critically ill patients with necrotizing soft tissue infections: a multicenter retrospective cohort study using the clinical data warehouse of Greater Paris University Hospitals.
    Windsor C; Hua C; De Roux Q; Harrois A; Anguel N; Montravers P; Vieillard-Baron A; Mira JP; Urbina T; Gaudry S; Turpin M; Damoisel C; Annane D; Ricard JD; Hersant B; Mekontso Dessap A; Chosidow O; Layese R; de Prost N;
    Ann Intensive Care; 2022 Dec; 12(1):115. PubMed ID: 36538244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrotizing soft tissue infection of the breast: case report and literature review.
    Aloisio da Costa Vieira R; Zucca Mathes AG; Michelli RA; Ribeiro GH; Haikel RL; Viana CR; Castro Pde T; Uemura G
    Surg Infect (Larchmt); 2012 Aug; 13(4):270-5. PubMed ID: 22870924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
    Young M; Plosker GL
    Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.
    Schoonover LL; Occhipinti DJ; Rodvold KA; Danziger LH
    Ann Pharmacother; 1995 May; 29(5):501-14. PubMed ID: 7655135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection.
    George ME; Rueth NM; Skarda DE; Chipman JG; Quickel RR; Beilman GJ
    Surg Infect (Larchmt); 2009 Feb; 10(1):21-8. PubMed ID: 18991520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological Etiology of Necrotizing Soft Tissue Infections.
    Skrede S; Bruun T; Rath E; Oppegaard O
    Adv Exp Med Biol; 2020; 1294():53-71. PubMed ID: 33079363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive Soft Tissue Infections.
    Garcia NM; Cai J
    Surg Clin North Am; 2018 Oct; 98(5):1097-1108. PubMed ID: 30243450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of mortality for necrotizing soft-tissue infections.
    McHenry CR; Piotrowski JJ; Petrinic D; Malangoni MA
    Ann Surg; 1995 May; 221(5):558-63; discussion 563-5. PubMed ID: 7748037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
    Yost RJ; Cappelletty DM;
    Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
    Varotto F; Maria GD; Azzaro R; Bellissima P; Amato R; Fogliani V; Muscianisi G; Vitale S; Girbino G; Andò F; Laganà P; Delia S; Jacoviello C; Maierna G; Pezza A; Covelli I; Magrì M; Napoletano G; Rossi A; Marone P; Sanguinetti C; Pela R; Tedeschi D; Viola B; Cicciarella S; Messina G; Rizza S; Fraschini F
    J Chemother; 2001 Aug; 13(4):413-23. PubMed ID: 11589485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.
    Gin A; Dilay L; Karlowsky JA; Walkty A; Rubinstein E; Zhanel GG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):365-83. PubMed ID: 17547502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Necrotizing Soft Tissue Infections: Case Reports, from the Clinician's Perspectives.
    Nedrebø T; Skrede S
    Adv Exp Med Biol; 2020; 1294():21-37. PubMed ID: 33079361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Piperacillin/tazobactam in the treatment of polymicrobial infections.
    Gorbach SL
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S27-34. PubMed ID: 7962986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necrotizing soft tissue infection of the thigh: consider an abdominal cause.
    Nijhof HW; Steenvoorde P; Bonsing BA; Hartgrink HH
    World J Surg; 2006 Oct; 30(10):1836-42. PubMed ID: 16957823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necrotizing soft tissue infections in the intensive care unit.
    Phan HH; Cocanour CS
    Crit Care Med; 2010 Sep; 38(9 Suppl):S460-8. PubMed ID: 20724879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tigecycline in the Treatment of Patients with Necrotizing Skin and Soft Tissue Infections Due to Multiresistant Bacteria.
    Eckmann C; Heizmann W; Bodmann KF; von Eiff C; Petrik C; Loeschmann PA
    Surg Infect (Larchmt); 2015 Oct; 16(5):618-25. PubMed ID: 26115414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are there any reasons to change our behavior in necrotizing fasciitis with the advent of new antibiotics?
    Menichetti F; Giuliano S; Fortunato S
    Curr Opin Infect Dis; 2017 Apr; 30(2):172-179. PubMed ID: 28134677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal Therapy in Fungal Necrotizing Soft Tissue Infections.
    Khoury MK; Heid CA; Cripps MW; Pickett ML; Nagaraj MB; Johns M; Lee F; Hennessy SA
    J Surg Res; 2020 Dec; 256():187-192. PubMed ID: 32711174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.